ArticleBMJ nutrition, prevention & health2025

Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation.

Kadalraja Raghavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.